US Stock MarketDetailed Quotes

CASI CASI Pharmaceuticals

Watchlist
  • 3.0700
  • -0.0100-0.32%
Trading Jan 7 14:31 ET
47.56MMarket Cap-1.38P/E (TTM)

CASI Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CASI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 14, 20242024/Q37.793M / 4.560M--
Aug 20, 20242024/Q23.979M / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--
Nov 1, 20232023/Q38.838M / 10.428M--
DatePeriodRevenue/EstimateEarnings Call
Nov 14, 20242024/Q37.793M / 4.560M--
Aug 20, 20242024/Q23.979M / 4.431M--
May 20, 20242024/Q13.409M / 12.000M--
Apr 1, 20242023/Q46.874M / 9.412M--
Nov 1, 20232023/Q38.838M / 10.428M--

Unlock Free Earnings Estimates

CASI Pharmaceuticals Earnings Reports

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 15, 2024 08:34 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 16, 2024 08:33 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    May 15, 2024 06:55 ET

  • CASI Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

    Mar 28, 2024 16:07 ET

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data